Skip to main content

Year: 2021

Pilgrim’s Supports Mayfield Recovery with $1 Million Investment

GREELEY, Colo., Dec. 13, 2021 (GLOBE NEWSWIRE) — Pilgrim’s, leading global food company and the largest employer in Graves County, Ky., today announced a $1 million investment to assist with community recovery needs and support long-term rebuilding efforts resulting from the recent tornado that impacted the area. “We are humbled to contribute to the relief efforts in our hometown of Mayfield,” said Kent Massey, Pilgrim’s Mayfield complex manager. “The community has always supported us, and we are focused on helping with the efforts to rebuild during this critical time.” Pilgrim’s will determine how funds will be spent as needs are identified, including potential partnerships with other organizations and local relief entities. The company will also provide assistance to its team members who were directly affected by the storm. “We...

Continue reading

Oma Savings Bank Plc – Acquisition of own shares on 13 December 2021

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 13 DECEMBER 2021 AT 21:05 P.M. EET, CHANGES IN COMPANY’S OWN SHARESOma Savings Bank Plc – Acquisition of own shares on 13 December 2021 At Nasdaq Helsinki Ltd (XHEL): Date: 13.12.2021Exchange transaction: BuyShare trading code: Oma Savings Bank Plc (OMASP)Amount, shares: 3,000Total cost, EUR: 48,625.00Average price/share, EUR: 16,208333Highest price/share, EUR: 16.30Lowest price/share, EUR: 16.15 The company holds a total of 154,355 of its own shares (OMASP) including the shares acquired on 13 December 2021. Detailed information concerning the acquisition is attached to this stock exchange release.On behalf of Oma Savings Bank Plc Nordea Bank Oyj Janne Sarvikivi         Sami HuttunenFurther information:Sarianna Liiri, CFO, tel +358 40 835 6712, sarianna.liiri@omasp.fiMinna Sillanpää, CCO,...

Continue reading

Proactive news headlines including Mountain Boy, CytoDyn, Tracesafe, Great Atlantic Resources, Fobi and Sigma Lithium

New York , Dec. 13, 2021 (GLOBE NEWSWIRE) —  Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:Global Energy Metals says MBK has exercised option to earn up to 80% of Millennium project in Queensland, Australia click here Anglo-US company gets $35mln funding from Shell, United Airlines and Amazon click here Mountain Boy confirms porphyry copper-gold mineralization, finds high-grade copper on its Telegraph project in British Columbia click here Altiplano Metals intersects high-grade copper at its Farellon mine in Chile click here Looking Glass Labs says its House of Kibaa studio airdrops 3D NFTs galleries to Genesis Membership holders click here CytoDyn announces positive preliminary results in Phase 2 trial open-label portion for nonalcoholic...

Continue reading

Convening Notice for Extraordinary General Meeting of Shareholders

Convening Notice for Extraordinary General Meeting of Shareholders MILLICOM INTERNATIONAL CELLULAR S.A.Registered Address:2, Rue du Fort BourbonL-1249 Luxembourg, Grand-Duchy of Luxembourg– R.C.S. Luxembourg: B40630 – I.   NOTICE The extraordinary general meeting (“EGM”) of the shareholders of MILLICOM INTERNATIONAL CELLULAR S.A. (“Millicom” or the “Company”) is hereby convened to be held at the Registered Address on Monday, January 24, 2022, at 4:00pm Central European Time (“CET“). The Company continues to monitor developments regarding the coronavirus disease (COVID-19) and related instructions from the Luxembourg Ministry of Health and other competent authorities in and outside of Luxembourg. Due to these circumstances, Millicom is taking precautionary measures to limit the exposure for its employees, shareholders and stakeholders,...

Continue reading

Skeljungur hf.: Chief of Governance and Quality resigns

Gróa Björg Baldvinsdóttir, Chief of Governance and Quality, has resigned from her post. Gróa has worked for Skeljungur since 2017 in various positions, including the posts of Chief Legal Counsel, Compliance Officer and Board Secretary. Since 2019, Gróa has served on the Company’s Executive Board, most recently as head of governance and quality, human resources and corporate culture. Árni Pétur Jónsson, Skeljungur CEO: “In recent years, Gróa Björg has been one of the Company’s key employees and an active participant in its strategic planning and business operation.  We thank Gróa for the pleasure of working with her and wish her the best of success in her future work.” www.skeljungur.is https://www.linkedin.com/company/skeljungur-hf/

Continue reading

Five Below Reunites With Bugha, 2019 Fortnite World Cup Champion, on New Product Collaborations

The extreme-value brand and Kyle “Bugha” Giersdorf continue to make the world of competitive gaming accessible for all with the launch of a new keyboard, mouse, headphones and moreExclusively available at Five Below beginning December 13, Five Below’s new product line in collaboration with Kyle Giersdorf (a.k.a. Bugha) feature RGB color-changing lights and other sought after features available at amazing value.New Gaming Products from Five Below in Collaboration with BughaFive Below’s new line of products in collaboration with Kyla Giersdorf (a.k.a. Bugha) is now exclusively available in-store and online for just $10 each. Featuring RGB color-changing lights and other sought after features, the product line up includes a sound bar, gaming headset and other essentials perfect for a gaming computer...

Continue reading

OSE Immunotherapeutics is Pleased to Announce the Continuation of its Phase 2 Trial Testing Anti-IL-7 Receptor Antagonist OSE-127/S95011 in Ulcerative Colitis after the Interim Futility Analysis

NANTES, France, Dec. 13, 2021 (GLOBE NEWSWIRE) — OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces today that the trial’s Independent Data Monitoring Committee (IDMC) completed the planned safety and efficacy assessment for futility of the ongoing Phase 2 clinical trial in Ulcerative Colitis patients and recommended continuation of the study. The randomized, double-blind Phase 2 clinical trial aims at assessing the efficacy and the safety of OSE-127/S95011 versus placebo in patients with moderate to severe active ulcerative colitis who have previously failed or lost response or are intolerant to previous treatment(s). The futility analysis has been conducted on the prespecified first 50 patients (i.e., 33% of the total patient enrollment in the study) having completed the Induction Phase. The primary endpoint...

Continue reading

Delisting of GrandVision on 10 January 2022

Delisting of GrandVision on 10 January 2022Settlement of the Offer took place on 8 December 2021 Post-Acceptance Period will end on 20 December 2021 The last trading date of the Shares on Euronext Amsterdam will be on 7 January 2022 and listing and trading of the Shares will terminate as of 10 January 2022 The Offeror will initiate statutory buy-out proceedings in order to obtain 100% of the SharesCharenton-le-Pont, France and Schiphol, the Netherlands (13 December 2021 – 6:00pm] CET) – EssilorLuxottica S.A. (the “Offeror”) and GrandVision N.V. (“GrandVision”) jointly announce that, considering that the Offeror holds more than 95% of the issued and outstanding shares in GrandVision (the “Shares”), Euronext approved the delisting of the Shares from Euronext Amsterdam. In consultation with Euronext, it has been decided that...

Continue reading

EssilorLuxottica : Delisting of GrandVision on 10 January 2022

Delisting of GrandVision on 10 January 2022Settlement of the Offer took place on 8 December 2021 Post-Acceptance Period will end on 20 December 2021 The last trading date of the Shares on Euronext Amsterdam will be on 7 January 2022 and listing and trading of the Shares will terminate as of 10 January 2022 The Offeror will initiate statutory buy-out proceedings in order to obtain 100% of the SharesCharenton-le-Pont, France and Schiphol, the Netherlands (13 December 2021 – 6 pm CET) – EssilorLuxottica S.A. (the “Offeror”) and GrandVision N.V. (“GrandVision”) jointly announce that, considering that the Offeror holds more than 95% of the issued and outstanding shares in GrandVision (the “Shares”), Euronext approved the delisting of the Shares from Euronext Amsterdam. In consultation with Euronext, it has been decided that delisting will...

Continue reading

Disclosure of transactions in own shares From December 06 to December 10, 2021

                                Paris, December 13rd, 2021                                            Disclosure of transactions in own shares From December 06 to December 10, 2021 Within the framework of the authorization granted by the General Meeting of VINCI SA of April 8, 2021 to trade in its shares and in accordance with the regulations relating to share buybacks, VINCI SA (LEI:213800WFQ334R8UXUG83) declares the purchases of treasury shares below (FR0000125486), carried out from December 06 to December 10, 2021: I- Aggregate presentation by day and by marketIssuer’sname Date of transaction Identifying code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares in Euro Market (MIC code)VINCI 06/12/2021 FR0000125486 10 396 86,5177 AQEUVINCI 06/12/2021 FR0000125486 16...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.